Dr. Patricia M Lorusso
Claim this profileYale Cancer Center
Expert in Tumors
Expert in Solid Tumors
22 reported clinical trials
38 drugs studied
Area of expertise
1Tumors
Global LeaderStage IV
MDM2 positive
Stage III
2Solid Tumors
Global LeaderStage IV
Stage III
TP53 positive
Affiliated Hospitals
Yale Cancer Center
Yale University School Of Medicine
Clinical Trials Patricia M Lorusso is currently running
PC14586
for Solid Tumors
This trial is testing a new oral drug, PC14586 (rezatapopt), alone and with pembrolizumab, in patients with advanced cancers that have a specific genetic mutation. The drug aims to fix a mutated protein to help control cancer growth. The study will determine the best dose and evaluate the drug's safety and effectiveness.
Recruiting1 award Phase 1 & 25 criteria
Aplitibart
for Metastatic Colorectal Cancer
This trial is testing a new drug called aplitibart with standard chemotherapy and another drug in patients with metastatic colorectal cancer that has come back or spread. The treatment works by killing cancer cells and cutting off their nutrient supply.
Recruiting1 award Phase 16 criteria
More about Patricia M Lorusso
Clinical Trial Related1 year of experience running clinical trials · Led 22 trials as a Principal Investigator · 10 Active Clinical TrialsTreatments Patricia M Lorusso has experience with
- TSR-022
- Pembrolizumab
- Entinostat
- ZEN003694
- IGM-8444
- FOLFIRI
Breakdown of trials Patricia M Lorusso has run
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Patricia M Lorusso specialize in?
Patricia M Lorusso focuses on Tumors and Solid Tumors. In particular, much of their work with Tumors has involved Stage IV patients, or patients who are MDM2 positive.
Is Patricia M Lorusso currently recruiting for clinical trials?
Yes, Patricia M Lorusso is currently recruiting for 10 clinical trials in New Haven Connecticut. If you're interested in participating, you should apply.
Are there any treatments that Patricia M Lorusso has studied deeply?
Yes, Patricia M Lorusso has studied treatments such as TSR-022, Pembrolizumab, Entinostat.
What is the best way to schedule an appointment with Patricia M Lorusso?
Apply for one of the trials that Patricia M Lorusso is conducting.
What is the office address of Patricia M Lorusso?
The office of Patricia M Lorusso is located at: Yale Cancer Center, New Haven, Connecticut 06510 United States. This is the address for their practice at the Yale Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.